-
Mashup Score: 28Source: www.abvp.orgCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 23Returning to work after cancer | Support and resources - 11 hour(s) ago
If you are thinking about going back to work after cancer treatment, we have information about how to manage the transition and getting employer support.
Source: www.macmillan.org.ukCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 13IO Foundation Course - 12 hour(s) ago
Discover the Interventional Oncology Foundation Course by CIRSE, a key opportunity for young interventionists exploring oncology treatments
Source: www.ecio.orgCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 3
The combination of trastuzumab and pertuzumab (HP) as part of a taxane-based regimen has shown benefit in the adjuvant and metastatic HER2+ breast cancer setting. In the CLEOPATRA trial, pruritus was reported in 11-17.6% of patients. The clinical phenotype …
Source: www.ncbi.nlm.nih.govCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 36Update in the molecular classification of endometrial carcinoma - 15 hour(s) ago
The pathological classification of endometrial carcinomas, one of the cornerstones in patient clinical management, has traditionally been based on morphologic features. However, this classification system does not fully reflect the biological diversity of endometrial carcinomas and has limited reproducibility. In the last decade, several studies have reported the strong prognostic value of the molecular endometrial carcinoma subgroups and, more recently, its potential to inform adjuvant treatment decisions. This has in turn resulted in a transition from a purely morphological classification towards an integrated histological and molecular system in the latest World Health Organization (WHO) classification of tumors of female reproductive organs. The new European treatment guidelines combine the molecular subgroups with traditional clinicopathological features in order to guide treatment decision-making. Accurate molecular subgroup assignment is therefore essential for adequate patient
Source: ijgc.bmj.comCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 2Boxcar Poetry Review - 17 hour(s) ago
Boxcar Poetry Review is an online literary magazine featuring new poetry, reviews of first books, and interviews with poets who have just published their first books.
Source: www.boxcarpoetry.comCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 13
Guidance for Industry, IRBs, and Clinical Investigators
Source: www.fda.govCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 11Offline: It is time to take cancer more seriously - 1 day(s) ago
The Lancet has published two Commissions in 2024 addressing the commonest cancers among men and women: prostate cancer (led by Nicholas James) and breast cancer (led by Charlotte Coles). As we were preparing these Commissions for publication, we considered writing an editorial linking the two cancers. But we hesitated. Surely these conditions are distinguished by their differences, not their similarities. Breast cancer is preventable. No such possibilities exist for prostate cancer. As our Commission on Prostate Cancer concluded: “The projected rise in prostate cancer cases cannot be prevented by lifestyle changes or public health interventions.” Yet, observing their launches and listening to the debates they provoked suggests that these cancers have more in common than might be appreciated—synergies that have important implications for accelerating cancer prevention and control.
Source: www.thelancet.comCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 3British man tests first personalised melanoma vaccine - 1 day(s) ago
Steve Young is part of the tests to see if an mRNA jab can stop the deadliest skin cancer returning.
Source: www.bbc.co.ukCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 11Offline: It is time to take cancer more seriously - 1 day(s) ago
The Lancet has published two Commissions in 2024 addressing the commonest cancers among men and women: prostate cancer (led by Nicholas James) and breast cancer (led by Charlotte Coles). As we were preparing these Commissions for publication, we considered writing an editorial linking the two cancers. But we hesitated. Surely these conditions are distinguished by their differences, not their similarities. Breast cancer is preventable. No such possibilities exist for prostate cancer. As our Commission on Prostate Cancer concluded: “The projected rise in prostate cancer cases cannot be prevented by lifestyle changes or public health interventions.” Yet, observing their launches and listening to the debates they provoked suggests that these cancers have more in common than might be appreciated—synergies that have important implications for accelerating cancer prevention and control.
Source: www.thelancet.comCategories: General Medicine News, Oncologists2Tweet
RT @ABVPVoice: Press Release (https://t.co/TT8UYIIVc3) ABVP submits memorandum to RBI governor demanding strict action against unlawful fr…